Diet & Nutrition News and Research

Latest Diet & Nutrition News and Research

Bid to raise awareness of risks and symptoms of ovarian cancer: The 2012 Teal Ribbon Day

Ovarian Cancer Australia has found less than one per cent of women know they're at risk if there's a family history of ovarian cancer on their father's side. And only 42 per cent know a history on their mother's side puts them at increased risk.

22 Feb 2012

Counterfeit drugs on the Internet find their way into legitimate pharmacies

Criminal gangs are increasingly using the internet to market life-threatening counterfeit medicines and some have even turned up in legitimate outlets such as pharmacies, according to a review led by Dr Graham Jackson, editor of IJCP, the International Journal of Clinical Practice, and published in the March edition.

22 Feb 2012

Some diets and diet pills may cause further kidney damage in overweight adults

With 1 in 5 overweight Americans suffering from chronic kidney disease, Cleveland Clinic researchers analyzed the nutritional and lifestyle habits of overweight adults, finding that their methods included diets and diet pills that may cause further kidney damage.

22 Feb 2012

Parental exposure to PFOA may increase risk of obesity in their daughters

The levels of the environmental pollutant perfluorooctanoic acid (PFOA) that mothers had in their blood during pregnancy increased the risk of obesity in their daughters at 20 years of age.

22 Feb 2012

Study examines impact of EHR on childhood obesity evaluation

Electronic health records and embedded tools can alert and direct pediatricians so they can better manage the weight of children and teenagers, according to a new Kaiser Permanente study published online in The Journal of Pediatrics.

22 Feb 2012

Study aims to achieve early detection of heart disease

With the month of February designated as Heart Health Month, physician-researchers in the Division of Cardiology at the Los Angeles Biomedical Research Institute (LA BioMed) - Dr. Matthew Budoff and Dr. Ronald Oudiz - continue to pave the way with their efforts to develop treatments and therapies for conditions affecting the heart, and to help improve overall heart health.

22 Feb 2012

NYSDOH approves Enzo Biochem's ColonSentry test

Enzo Biochem, Inc. today announced that the New York State Department of Health has approved Enzo Clinical Labs' use of the ColonSentry test for providing an assessment of a patient's risk of having colorectal cancer.

22 Feb 2012

Childhood Obesity celebrates second anniversary of Let's Move! initiative

Faith-based advocacy has been cited as a valuable tool in combating childhood obesity, but evidence is needed to support this assertion and to define how the link between advocacy and policy can contribute to promoting permanent lifestyle changes. This article is part of a special issue of the journal Childhood Obesity celebrating the second anniversary of First Lady Michelle Obama's Let's Move! initiative.

22 Feb 2012

FDA approves APP's preservative-free Methotrexate Injection

APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market preservative-free Methotrexate Injection, USP. APP currently manufactures Methotrexate Injection with preservative.

22 Feb 2012

Foreign-born Hispanics in the U.S. might have lower risk of stroke

New research finds foreign-born Hispanics now living in the United States appear to be less likely to have a stroke compared to non-Hispanic white people.

22 Feb 2012

VTT participates in two new EU projects that focus on type 2 diabetes

VTT is participating in two new European projects focusing on type 2 diabetes. The projects aim at identifying new therapeutic choices and strategies for preventing the disease. Focus is on obtaining information on cellular dysfunction in diabetes and the effects of changes in lifestyle. The goal includes planning individual lifestyle instructions for people at high risk of diabetes and exploiting the results in a major European health insurance system.

22 Feb 2012

BioLineRx BL-7010 may reduce gluten toxicity in patients with celiac disease

BioLineRx, a biopharmaceutical development company, announced the publication of pre-clinical results demonstrating that BL-7010, an orally available treatment for celiac disease, reduces gluten toxicity (the negative effect of gluten on the patient's body).

22 Feb 2012

AChemS recognizes Monell Center molecular biologist as outstanding junior scientist

Molecular biologist Ichiro Matsumoto, Ph.D., of the Monell Center, is the recipient of the 2012 Ajinomoto Award for Young Investigators in Gustation, awarded annually by the Association for Chemoreception Sciences (AChemS) to an outstanding junior scientist who is an emerging leader in the field of gustation.

22 Feb 2012

Fructose may not be to blame for obesity

Is fructose being unfairly blamed for the obesity epidemic? Or do we just eat and drink too many calories? Researchers from St. Michael's Hospital reviewed more than 40 published studies on whether the fructose molecule itself causes weight gain.

22 Feb 2012

UMC Utrecht, DSM collaborate for Dyneema Purity fiber technology

DSM, a global leader in biomedical materials sciences, and University Medical Center Utrecht, a leading academic hospital with a renowned experimental facility unit for cardiothoracic interventions today announced that they have entered into a collaboration agreement.

22 Feb 2012

Series of studies on rising obesity rates among kids

New figures show that nearly a quarter of secondary school students are overweight or obese, and lifestyle and socio-economic status are implicated. The research was funded by Cancer Councils around Australia and the National Heart Foundation. A series of articles published in the Medical Journal of Australia draws attention to the challenges presented by overweight and obesity to people in a variety of age groups especially children.

21 Feb 2012

FDA to review rejected weight loss drug Qnexa

The weight loss pill Qnexa has been once rejected by the FDA over safety concerns. But this Wednesday it will get a second chance before an FDA advisory committee. Qnexa maker Vivus Inc. hopes something might come out of this second chance. The company will be submitting new safety data from patients who took Qnexa for a second year after completing a one-year clinical trial.

21 Feb 2012

Sitting for long hours affects hips, spine, shoulders and the heart

You may feel productive putting in long days at the office. But while your mind is active, your body isn't. There is a growing body of research that supports the idea that, regardless of your exercise routine after hours, the more time you spend sitting each day, the higher your risk of heart disease. Evidence suggests your hips, spine and shoulders suffer as well.

21 Feb 2012

Birmingham dermatologist first to offer anti-cellulite Cellulaze procedure

Dr. Barry Ginsburg, a Birmingham, AL based Dermatologist today announced his practice is the first in the state to offer the Cellulaze by Cynosure, the world's first and only minimally invasive medical device designed to treat women who have struggled to eliminate cellulite through diet and exercise, or have tried the myriad of lotions and creams currently on the market.

20 Feb 2012

Lack of diapers keep children out of childcare

According to the most recent census, 22% of American children live at or below the poverty line. In many cases, their families cannot provide the diapers they need because diapers, which can cost as much as $100 a month, cannot be bought with the federal Supplemental Nutrition Assistance Program (SNAP, commonly known as "food stamps") or the Special Supplemental Nutrition Program for Women, Infants, and Children.

20 Feb 2012